Prime Medicine, Inc. (PRME) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 516.19M |
| Enterprise Value | 569.59M |
| P/E Ratio | -2.85 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 138.8 |
| Price/Book Ratio | 13.93 |
| Enterprise/Revenue | 154.77 |
| Enterprise/EBITDA | -3.49 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -46.13 |
| Operating Margin | -48.25 |
| Return On Assets | -0.75 |
| Return On Equity | -1.88 |
| Revenue | 4.63M |
| Revenue/Share | 0.02 |
| Gross Profit | -2.69M |
| EBITDA | -195.76M |
| Net Income | -201.14M |
| Diluted EPS | -1.35 |
| Total Cash | 95.07M |
| Total Cash/Share | 0.54 |
| Total Debt | 112.48M |
| Total Debt/Equity | 2.83 |
| Current Ratio | 3.05 |
| Book Value Per Share | 0.22 |
| 52-Week Change | -23.28 |
| 52-Week High | 6.94 |
| 52-Week Low | 2.67 |
| Moving Average 50 Days | 3.38 |
| Moving Average 200 Days | 3.54 |
| Average Volume | 3.27M |
| Shares Outstanding | 180.62M |
| % Held by Institutions | 60.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |